ERBB2 and breast carcinoma: We found potential interactions between EGFR and PLC-γ activities, which have a role in breast cancer, whereby EGFR/human epidermal growth factor receptor 2/PLC-γ1 signaling results in tumor cell invasion and migration [25, 68, 69].